Viveo
Viveo is a Brazilian vertically integrated healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, and consumer health products across Brazil through 40+ operational units serving 10,000+ hospitals, 80,000 pharmacies, and 70,000 supermarkets.
- Company typePublic
- Founded1996
- HeadquartersRibeirão, Brazil
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Viveo does
Viveo is a vertically integrated Brazilian healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, sterile compounds, and consumer health products. Operating under legal entity CM Hospitalar S.A. and publicly listed on B3 (ticker VVEO3), the company runs 40+ operational units nationwide including 26+ distribution centers, 7 manufacturing factories, 12 sterile compounding pharmacies, and a proprietary fleet of 263 vehicles covering 900,000+ km/month. The ecosystem reaches 80% of Brazilian private hospitals within 24 hours and delivers to 10,000+ hospital/clinic units, 80,000 pharmacies, and 70,000 supermarkets. Major operating brands include Mafra (hospital/clinic distribution), Tecnocold (vaccines), Prevena (diagnostics), Cremer (first aid and consumer health), Neve (medical textiles), Healthlog (logistics), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), and Insuma (sterile compounding). The company employs 6,500-7,000 people and holds dominant positions in Brazilian wet wipes (50% market share including white-label) and private vaccine distribution (50%+ market share).
Viveo firmographics
Firmographics- Name
- Viveo
- Legal name
- CM Hospitalar S.A.
- Website
- https://viveo.com.br
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Viveo is a Brazilian vertically integrated healthcare ecosystem that manufactures, distributes, and delivers pharmaceuticals, medical materials, vaccines, diagnostics, and consumer health products across Brazil through 40+ operational units serving 10,000+ hospitals, 80,000 pharmacies, and 70,000 supermarkets.
- Ownership category
- akta.pro rank
Viveo industry classification
Industry- Product category
- Healthcare Distribution and Manufacturing
- NAICS
- Soap and Cleaning Compound Manufacturing (32561), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Soap and Other Detergent Manufacturing (325611)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840), Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Personal Care Wipes & On-the-Go Hygiene (Non-medical) (CRADANAJ)
- akta.pro secondary industry
- Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)
Keywords
Where Viveo is headquartered
LocationHeadquarters
- HQ city
- Ribeirão
- HQ country
- Brazil
- HQ region
- Latin America
Offices13 records
Markets served
Viveo business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Manufacturing & Product Sales: Viveo manufactures healthcare products including first-aid supplies, bandages, wet wipes, cotton products, surgical materials, hospital textiles, and private-label consumer goods. Revenue is generated through one-time product sales to pharmacies, supermarkets, hospitals, and industries. The company operates 7 factories across Brazil producing over 11 million packets of wet wipes per month and is the largest wet wipes manufacturer in Latin America.
- Distribution of Medical Products & Medications: Distribution of medications, medical materials, hospital supplies, and specialty nutrition through a national network of distribution centers. The company operates 26+ distribution centers and uses its own fleet of 263 vehicles, covering all five Brazilian regions and delivering to 80% of private hospitals within 24 hours. Revenue from distribution fees embedded in product pricing.
- Medication Subscription (Far.me): Direct-to-consumer medication subscription service acquired through the 100% acquisition of Far.me (Belo Horizonte-based healthtech). The subscription model delivers medications regularly to end consumers, generating recurring subscription revenue.
- Diagnostic Distribution & Services (Prevena): Prevena acts as a one-stop-shop diagnostic platform distributing pre-analytical products, reagents, lab equipment (Roche cobas, Sysmex urinanalysis), and providing technical support and logistics to clinical laboratories. Revenue from product distribution with integrated service support.
- Vaccine Distribution (Tecnocold): Tecnocold distributes vaccines to approximately 100% of private clinics in Brazil and over 50% of the private vaccine market. Revenue from vaccine distribution and cold-chain logistics services, with presence at major industry events (ABCVAC).
- Logistics & Supply Chain Services (Healthlog): Healthlog provides integrated logistics services including transport, inventory management, and storage for healthcare products. With its own fleet covering over 900,000 km/month, revenue is generated through logistics service fees.
- Patient Support Programs (Humania): Humania operates Patient Support Programs (PSP) providing adherence programs, treatment monitoring, and strategic solutions for pharmaceutical companies, health insurers, and private companies. Revenue from service contracts.
- Sterile Compounding Pharmacies (Insuma): Insuma operates sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers across Brazil, positioned as the largest sterile compounding network in Latin America. Revenue from compounded pharmaceutical preparations.
- Private Label Manufacturing: Viveo's Private Label division manufactures products under retailer and brand owner labels, including wet wipes, hygiene products, and personal care items for major Brazilian retailers and multinational companies. Revenue from B2B manufacturing contracts.
Go-to-market motion2 records
Distribution channels7 records
Marketing channels7 records
Viveo product offering
Product offeringCore offering
Viveo is a Brazilian healthcare ecosystem that manufactures and distributes medical materials, medications, hospital supplies, vaccines, diagnostics, sterile injectables, and consumer healthcare products. The company operates 7 factories, 26+ distribution centers, and a fleet of 263 vehicles to serve hospitals, clinics, laboratories, pharmacies, and supermarkets across Brazil through a portfolio of specialized brands including Mafra, Cremer, Tecnocold, Prevena, Insuma, Neve, Healthlog, and Humania. The company also offers patient support programs and direct-to-consumer medication subscription via Far.me.
Product overview
Viveo is a Brazilian healthcare ecosystem comprising multiple business units that operate as an integrated platform. The company offers manufacturing, distribution, logistics, and digital services across the healthcare value chain. Key business units include Mafra (hospital/clinic distribution), Tecnocold (vaccine distribution serving 50%+ of private market), Prevena (diagnostic products distribution with Roche/Sysmex partnerships), Cremer (first aid/hygiene manufacturing and retail with brands Topz/Bellacotton/Salvelox/Piquitucho/FeelClean), Neve (medical textiles), Healthlog (logistics with 900,000+ km/month coverage), Humania (patient support programs), Mafra Especialidades (specialty pharmacy), Insuma (sterile compounding pharmacy network - Latin America's largest), and a Private Label division (contract manufacturing with 8 factories producing wet wipes and personal care products). The ecosystem also operates Customer Care, a digital platform for order management with virtual assistant Mel. Viveo distributes to hospitals, clinics, laboratories, pharmacies, retailers, and end consumers across Brazil.
Differentiator
Problem solved
Functional benefit
Brands
- Mafra Saúde: One stop shop for healthcare distribution
- Tecnocold Vacinas
- Prevena
- Cremer
- Neve Medical
- Health Log
- Humania
- Insuma
- Embramed
- Topz
- Bellacotton
- Salvelox
- Piquitucho
- FeelClean
Products and services
- Mafra One-stop-shop distribution company operating across multiple healthcare segments including medications, medical materials, hospital nutrition, and OPME (ortheses, prostheses, and medical devices). Serves hospitals and clinics through specialized verticals for high-complexity medications and surgical products.
- Tecnocold Vacinas Market leader in vaccine distribution serving over 50% of Brazil's private vaccine market with presence in virtually 100% of private vaccine clinics. Operates the largest vaccine distribution center in Cajamar (SP) with the largest cold storage chamber in the market.
- Prevena Diagnóstica Diagnostic distribution platform serving as a one-stop-shop delivering complete solutions from pre-analytical to analytical phases for clinical laboratories. Distributes products from Roche (cobas 8000 modular analyzer), Sysmex (urinanalysis), Neolab (collection tubes), and Autobio (hemoculture systems).
- Cremer Manufacturer and distributor of first aid, surgery, treatment, hygiene, and personal care products with over 88 years of experience. Serves both pharmacy and supermarket channels with owned brands including Piquitucho, Topz, Bellacotton, Salvelox, and FeelClean. Operates own wet wipes manufacturing.
- Neve Medical Manufacturer and distributor of medical textile products recognized for quality with RDC 16/2013 ANVISA Good Manufacturing Practices certification. Supplies hospital textiles, surgical materials, and medical clothing products to hospitals and clinics across Brazil.
- Healthlog Integrated logistics services platform with proprietary fleet of 263 vehicles covering over 900,000 km/month and delivering throughout Brazil. Offers transport, inventory management, and storage services for healthcare products, with 8 fully electric trucks in Greater São Paulo.
- Humania Patient Support Program (PSP) specialist offering humanized, innovative, and strategic solutions for pharmaceutical industry, health insurers, and private companies. Supports patient adherence programs, treatment monitoring, and specialty therapy management including oncology and infusion therapy.
- Mafra Especialidades Specialty medications and materials distribution for retail and healthcare professionals with proximity service, speed, and complete assortment. Operates physical stores and online with Brazil-wide delivery of specialty pharmaceutical products.
- Insuma National network of sterile injectable compounding pharmacies serving hospitals, clinics, and health insurers. Portfolio includes enteral, parenteral, dialysis, and oncology solutions. Operates 12 sterile compounding pharmacies across Brazil.
- Private Label Division Contract manufacturing division offering high-technology products for national and international brands in Latin America. Operates 8 factories producing wet wipes, hygiene products, first aid items, and personal care solutions with over 11 million wet wipe packages per month capacity. Serves major Brazilian retailers and multinational brands.
- Far.me Medication Subscription Direct-to-consumer medication subscription service delivering medications regularly to end consumers. Subscription model launched since 2020 serving chronic medication patients with home delivery across Brazil.
- Boxifarma Automated Pharmaceutical Services AI and robotics-driven personalized medication packaging technology that automates pharmaceutical dispensing and improves treatment management for patients. Uses Boxifarma's automated services to deliver customized multi-dose packaging through partner pharmacies.
- Customer Care Platform Digital customer service platform featuring Mel, a virtual assistant for simplified and secure order management. Offers features including duplicate invoices, fiscal documents, delivery receipts, technical complaints, and business policies access for B2B clients.
Quantifiable outcome
- Viveo generates R$11.6 billion in annual revenue with R$706.3 million in adjusted EBITDA, demonstrating operational scale as Brazil's largest healthcare ecosystem
- +5 more outcomes
Companies that use Viveo
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles6 records
Viveo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Viveo partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and supporting.
- PapiruscoreViveo and Papirus developed sustainable packaging for Cremer products using Vitacycle® paperboard with 40% post-consumer recycled content. The partnership includes the Papirus Circular Program for packaging traceability and recycling credits, involving Gráfica Edelmann (production) and Polen cleantech (carbon credit tracking). The project avoided 194 tonnes of CO2 equivalent emissions and processed 328+ tonnes of post-consumer material. The award-winning packaging covers Cremer, Bellacotton, and Topz brands.
- PolensupportingPolen is a cleantech partner in the Papirus Circular Program tracking 100% of input invoices for post-consumer recycled material. Generates recycling credits for Viveo's sustainable packaging and provides a real-time impact tracking landing page (lps.brpolen.com.br/viveo).
- Roche DiagnósticacoreRoche Diagnóstica partnered with Prevena (Viveo brand) to deploy the cobas® 8000 modular analyzer series in Brazilian clinical laboratories. The platform performs up to 9,800 tests/hour with 99%+ uptime. Prevena handles distribution, installation, technical support, and workflow optimization for Roche's high-throughput diagnostic platform across Brazil.
- SysmexsupportingSysmex supplies urinanalysis technology distributed through Prevena, one of four major innovations launched by Prevena at CBAC 2025.
- AutobiosupportingAutobio hemoculture system is a new brand launched in Brazil through Prevena at CBAC 2025, expanding Prevena's diagnostic portfolio.
- NeolabsupportingNeolab collection tubes are an international brand being launched in Brazil through Prevena at CBAC 2025, expanding Prevena's pre-analytical portfolio.
- Childhood BrasilsupportingChildhood Brasil partnered with Cremer (Viveo brand) to launch Curativos dos Direitos da Criança — bandages printed with phrases written by children to raise awareness about children's rights. Product available in pharmacies nationwide with QR Code linking to the organization's website. Created by Pullse agency.
- AllergansupportingViveo holds a dermatology vertical contract for Allergan's botulinum toxin (Botox), which started generating increased sales and margin gains in Q3 2024. Viveo distributes Allergan's high-value dermocosmetics and botulinum products through its pharmaceutical distribution network.
- Sociedade Brasileira de Análises Clínicas (SBAC)supportingPrevena participates in the CBAC congress organized by SBAC (50th edition in 2025), the largest clinical laboratory congress in Brazil, as an independent exhibitor for the first time since its 2022 launch.
- Associação Brasileira de Clínicas de Vacinas (ABCVAC)supportingTecnocold participates in ABCVAC congress (June 2025 in São Paulo), leveraging the event to expand networking, understand market trends, and discuss relevant sector topics with private vaccine clinic professionals across Brazil.
- SESIsupportingViveo partners with SESI for the 'Bem Nutrir' nutritional care program, sharing healthy eating information with professional nutritionists. SESI also partners on PCD (persons with disabilities) vocational training initiatives.
Scale indicators40 records
Recent moves7 records
Expansion highlights7 records
Viveo competitors and assessment
Company assessmentDirect peers
- Hyper Pharma (Hypera S.A.): Brazil's largest pharmaceutical company (HYPERA3), manufacturing branded generics, OTC, and consumer health products with strong distribution. Highly comparable to Viveo given its combination of pharma manufacturing, consumer health brands, and broad Brazilian distribution scale.
- Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with vertically integrated operations spanning branded generics, OTC, hospital, and prescription segments. Comparable to Viveo's Mafra and Cremer business units given its manufacturing-plus-distribution model serving both B2B and consumer channels.
- Diagnósticos da América (Dasa): Brazil's largest diagnostic medicine company (DASA3), operating clinical analysis labs and imaging centers nationwide. Directly comparable to Viveo's Prevena brand given overlap in clinical laboratory supply, diagnostic equipment distribution, and laboratory services to the same hospital/clinic customer base.
- EMS Pharma: Largest Brazilian pharmaceutical company by units sold, with a broad portfolio across prescription, generics, OTC, and consumer health. Comparable to Viveo given its national distribution scale and diversified healthcare product portfolio reaching pharmacies and hospitals.
- Fleury: Major Brazilian diagnostic and clinical analysis company (FLRY3) operating labs and imaging centers. Comparable to Viveo's Prevena diagnostic distribution and laboratory services business given shared focus on serving the Brazilian clinical laboratory market with diagnostic products and services.
- Grupo NC (formerly Hypermarcas): Brazilian consumer goods conglomerate spanning personal care, cosmetics, and household products. Comparable to Viveo/Cremer's branded consumer healthcare business (Topz, Bellacotton, Piquitucho, FeelClean) given shared focus on Brazilian CPG distribution through pharmacy and supermarket channels.
Broad incumbents
- Cardinal Health: US-based healthcare distribution and medical products company serving hospitals, pharmacies, and clinical laboratories globally. Comparable to Viveo's distribution business model across pharmaceuticals, medical-surgical products, and laboratory supplies at a broader geographic and category scale.
- McKesson Corporation: Global pharmaceutical distribution and healthcare services leader. Comparable to Viveo's Mafra and Healthlog distribution operations given the shared pharmaceutical distribution business model and end-to-end healthcare supply chain focus, though at vastly larger global scale.
Regional players
- Raia Drogasil (RD Saúde): Brazil's largest pharmacy retail chain (RADL3) with 2,500+ stores. Comparable to Viveo as a downstream customer (80,000 pharmacies served by Cremer) and adjacent market participant in Brazilian consumer healthcare, though operating in retail rather than distribution/manufacturing.
- Pague Menos: Major Brazilian pharmacy retail chain (PGMN3) with extensive nationwide footprint. Comparable to Viveo as a downstream channel for Cremer consumer healthcare products and as an adjacent participant in the Brazilian consumer health retail market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Viveo social profiles
Digital presenceViveo compliance and trust
Trust signalCompliance8 records
Viveo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Viveo leadership team
Management profileNumber of profiles
Profiles10 records
Viveo subsidiaries and ownership
Company hierarchySubsidiaries21 records
Viveo funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Viveo M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Viveo
What does Viveo do?
Viveo is a Brazilian healthcare ecosystem that manufactures and distributes medical materials, medications, hospital supplies, vaccines, diagnostics, sterile injectables, and consumer healthcare products. The company operates 7 factories, 26+ distribution centers, and a fleet of 263 vehicles to serve hospitals, clinics, laboratories, pharmacies, and supermarkets across Brazil through a portfolio of specialized brands including Mafra, Cremer, Tecnocold, Prevena, Insuma, Neve, Healthlog, and Humania. The company also offers patient support programs and direct-to-consumer medication subscription via Far.me.
Is Viveo a public or private company?
Viveo is a public company. It is classified as public and is currently operating.
When was Viveo founded?
Viveo was founded in 1996. It employs 5,001 to 10,000 people.
Where is Viveo based?
Viveo is headquartered in Ribeirão, Brazil, in the Latin America region.
How does Viveo make money?
Nine revenue lines are on record. Manufacturing & Product Sales are the primary driver. The others are distribution of Medical Products & Medications, medication Subscription (Far.me), diagnostic Distribution & Services (Prevena), vaccine Distribution (Tecnocold), logistics & Supply Chain Services (Healthlog), patient Support Programs (Humania), sterile Compounding Pharmacies (Insuma) and private Label Manufacturing.
Who are Viveo's main competitors?
Direct peers on record are Hyper Pharma (Hypera S.A.), Eurofarma Laboratórios, Diagnósticos da América (Dasa), EMS Pharma, Fleury and Grupo NC (formerly Hypermarcas). Broad incumbents are Cardinal Health and McKesson Corporation. Regional players are Raia Drogasil (RD Saúde) and Pague Menos.
Does Viveo have an API?
No public API is recorded for Viveo.
What industry is Viveo in?
Viveo's product category is Healthcare Distribution and Manufacturing. Its primary akta.pro industry code is CRADANAJ, Personal Care Wipes & On-the-Go Hygiene (Non-medical), with a secondary code of HLAGALAK, Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support). Its NAICS code is 32561 and its SIC code is 5047.